Search

RCOphth 2024 Report

A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

New online tool will be a critical planning resource for commissioners and providers of eye health care

Eye disease is a major contributor to national health service backlogs, and the number of cases is set to significantly increase with an ageing population. Organisations from across the UK’s eye care sector, including the Association of British Dispensing Opticians...

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

Genetic therapy gives infants life-changing improvements in sight

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx. The children were born with a severe impairment to...

Conference Report: RCOphth 2025

This year’s Royal College of Ophthalmologists Annual Congress in Liverpool brought together eyecare professionals from across the country and beyond for four days of thought-provoking content, collaborative discussion and exciting glimpses into the future of ophthalmology. The opening day was...

Has ‘reduce, reuse and recycle’ gone too far?

The past few decades of surgery since the ‘mad cow disease’ have been dominated by a push to switch to disposable instruments. The reason is to prevent cross-contamination and reduce the risk of surgical site infections – especially so with...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

BMLA 2023 Annual Conference & Educational Courses

Navroz Singh (far right) with Nirmal and Vasant Oswal (second and third left) and the other recipients of the Vasant and Nirmal Oswal Trainee Scholarship. Navroz Singh, core surgical trainee at Kings College NHS Trust. This year’s British Medical Laser...

BMLA Annual Conference & Educational Courses

Navroz Singh, core surgical trainee at Kings College NHS Trust. This year’s British Medical Laser Association (BMLA) annual conference was held over three days in a beautiful venue overlooking a sunny Cardiff Bay. It was attended by individuals hailing from...